Foundation certificate course in Medical Information and Drug Safety Associate

Course Description

This 30-hour Foundation Skill Development Programme prepares students for the Medical Information Associate (MIA) role, covering the full scope of pharmacovigilance and medical information functions — from AE case intake, triage, and narrative writing to signal detection, aggregate safety reporting (PSUR/PBRER/DSUR), medical inquiry handling, literature evaluation, PQC coordination, and regulatory compliance (FDA, CDSCO, EMA, NDCT, ICH-GVP). Delivered through lectures, case-based discussion, and hands-on simulation, industry-ready skill gaps. Learning Outcome: Learners will be equipped to perform end-to-end AE case processing, respond compliantly to medical inquiries, and support regulatory documentation in an industry setting.

Course Fee Seats Limited

₹2500.00

Course Details

Duration
Duration
30 HRS
Duration
Course Label
SkillDevelopment
Certificate
Certificate
Yes
Course Language
English
Duration
Course Mode
Online
Duration
Timings
7 PM - 8 PM
Days
Monday to Friday
Registration Till
25 Aug 2026
Duration
Tentative ClassStart Date
1st Week of September
Duration
Eligible Schools:
Certificate Criteria
Certificate Criteria
75% attendance, 50% score in all Exams/CA

Curriculum Snapshot

Explore the comprehensive course modules

1 Module 1: Foundations: MIA Role, Medical Affairs PV Ecosystem

?MIA job profile: scope, KPIs, stakeholders, global regulated-environment expectations ?Overview of Medical Affairs / PV / RA / QA interfaces and hand-offs ?FDA post-marketing safety reporting framework (21 CFR 314.80/600.80), MedWatch, safety terminology primer History & structure of WHO international drug monitoring programme and PvPI

2 Module 2: Adverse Event Case Processing Intake

?Four minimum criteria for a valid ICSR (identifiable patient/reporter, suspect product, event) ?Multi-channel intake protocols and CRM-based logging ?Causality assessment methods (WHO-UMC, Naranjo) and seriousness/expectedness grading ?AE narrative writing practice from raw case notes

3 Module 3: Signal Detection Management

?Passive surveillance (spontaneous reports, case series) vs active surveillance (sentinel sites, registries) ?Introductory disproportionality concepts (PRR/ROR) for signal detection Signal validation, prioritisation and management workflow in industry practice

4 Module 4: Aggregate Safety Report Writing

?ICH E2C(R2) PBRER/PSUR structure walk-through; DSUR basics ?Data aggregation, tabulation and simple descriptive statistics for safety data Benefit-risk narrative writing practice using a template

5 Module 5: Medical Information Inquiry Management Literature Evaluation

?Inquiry classification, response timelines and channel-appropriate handling ?Literature search strategy and evidence-hierarchy based critical evaluation ?SRD/FAQ authoring standards and inquiry database/tracking practice

6 Module 6: Product Quality Complaints Cross-Functional Coordination

?PQC intake, classification and triage ?Cross-functional coordination workflow with QA/RA teams ?Documentation and closure of a PQC case

7 Module 7: Regulatory Compliance Support

?Comparative overview of FDA, CDSCO, EMA structures relevant to MI/PV ?Schedule Y, GCP obligations and pharmacovigilance in clinical trials Regulatory documentation and inspection-readiness checklist practice

8 Module 8: Medical Regulatory Writing Skills

?Narrative-writing conventions for AE/PQC cases ?Tone, style and compliance considerations in regulated medical writing ?Structured practice: drafting a custom HCP inquiry response

9 Module 9: Communication, Documentation Quality Mindset

?Multi-channel communication practice (phone/email/chat) and handling difficult conversations ?Documentation discipline, attention to detail and cross-functional teamwork simulation

Instructor Spotlight

Learn from leading experts in stem cell research

Dr. Kanav Khera

Dr. Kanav Khera

Professor

Working as Professor, Dept of Pharmacology/Pharmacy Practice, with more than 15 years of experience in Clinical Research/Biomedical Ethics/Evidence-based medicine, Antibiotic Stewardship program, pharmacovigilance, Drug Safety, Clinical trials, and outcome research. Dr Kanav Khera is also associate member secretory of Institutional ethics committee at School of Pharmaceutical Sciences, LPU. Dr Kanav Khera had vast experience in providing Pharmaceutical care services in Tertiary care hospitals and handling medication errors and related problems. Had published more than 35 research papers in National and international journals and was invited as a guest speaker at various events.